retatrutide phase 2 trial type 2 diabetes weight loss 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No plateau — curve still descending Retatrutide as a Novel Treatment

Retatrutide is not recommended during pregnancy or breastfeeding

As part of our Canadian Telehealth services for Ozempic prescriptions, one of our practitioners will determine whether they believe Ozempic makes sense for you

When discussed in the media, it has been nicknamed Triple G. By working on three hormones, retatrutide has been demonstrated in clinical trials to help reduce appetite, control blood sugar, and promote fat loss

The best way to prevent that is by focusing on nutrition, movement, and self-care while youre still on the medication

Related : Novo Nordisk vs Bariatric Surgery vs Junk Food Once youve registered, your doctor will prescribe Ozempic